Enlivex Therapeutics Ltd. (ENLV) Financials

$1.04

$0.01 (0.97%)
Last update: 04:00 PM EST
Day's range
$1
Day's range
$1.08
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40M-$50M-$50MEarning20182018201920192020202020212021202220222023202320242024-607%-607%-607.5%-607.5%-608%-608%-608.5%-608.5%-609%-609%-609.5%-609.5%-610%-610%Profit Margin
Profit Margin
Revenue
Earnings

ENLV Income statement / Annual

Last year (2024), Enlivex Therapeutics Ltd.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Enlivex Therapeutics Ltd.'s net income was -$15.01 M. See Enlivex Therapeutics Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $2.28 M $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $545.00 K $835.00 K $777.00 K $546.00 K $286.00 K $297.00 K $121.00 K $12.00 K $25.00 K $17.00 K
Gross Profit -$545.00 K -$835.00 K -$777.00 K -$546.00 K $1.99 M -$297.00 K -$121.00 K -$12.00 K -$25.00 K -$17.00 K
Gross Profit Ratio 0 0 0 0 0.87 0 0 0 0 0
Research and Development Expenses $10.13 M $19.24 M $18.69 M $12.88 M $6.09 M $5.72 M $4.26 M $2.52 M $8.88 M $7.69 M
General & Administrative Expenses $0.00 $6.14 M $6.70 M $6.24 M $3.60 M $2.75 M $937.00 K $2.96 M $6.99 M $6.95 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $479.00 K $0.00 $829.00 K
Selling, General & Administrative Expenses $4.87 M $6.14 M $6.70 M $6.24 M $3.60 M $2.75 M $937.00 K $3.44 M $6.99 M $7.78 M
Other Expenses $0.00 $4.02 M $402.00 K $167.00 K $97.00 K $145.00 K $0.00 $0.00 $0.00 -$829.00 K
Operating Expenses $14.99 M $29.40 M $25.80 M $19.29 M $9.79 M $8.62 M $5.30 M $5.96 M $15.87 M $15.48 M
Cost And Expenses -$15.54 M $29.40 M $25.80 M $19.29 M $9.79 M $8.62 M $5.30 M $5.96 M $15.87 M $15.48 M
Interest Income $1.07 M $1.57 M $835.00 K $120.00 K $225.00 K $238.00 K $138.00 K $39.00 K $90.00 K $186.00 K
Interest Expense $0.00 $14.00 K $5.26 M $328.00 K $6.00 K $7.00 K $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $545.00 K $835.00 K $777.00 K $546.00 K $286.00 K $297.00 K $121.00 K $12.00 K $25.00 K $17.00 K
EBITDA -$14.47 M -$28.22 M -$25.02 M -$18.74 M -$9.50 M -$9.08 M -$5.18 M -$5.91 M -$15.78 M -$15.31 M
EBITDA Ratio 0 0 0 0 -4.17 0 0 0 0 0
Operating Income Ratio 0 0 0 0 -4.3 0 0 0 0 0
Total Other Income/Expenses Net $522.00 K $327.00 K -$5.26 M $4.82 M -$2.04 M -$765.00 K $1.06 M -$67.00 K -$1.86 M $135.00 K
Income Before Tax -$15.01 M -$29.07 M -$31.06 M -$14.47 M -$11.82 M -$9.38 M -$4.24 M -$5.92 M -$15.81 M -$15.34 M
Income Before Tax Ratio 0 0 0 0 -5.19 0 0 0 0 0
Income Tax Expense $0.00 $0.00 $11.35 M -$4.82 M $2.04 M $765.00 K $1.06 M $28.00 K $216.00 K $24.00 K
Net Income -$15.01 M -$29.07 M -$42.41 M -$9.65 M -$13.86 M -$10.15 M -$4.24 M -$5.95 M -$16.02 M -$15.37 M
Net Income Ratio 0 0 0 0 -6.09 0 0 0 0 0
EPS -0.73 -1.56 -2.31 -0.54 -1.05 -1.17 -1.21 -14.35 -40.29 -43.19
EPS Diluted -0.73 -1.56 -2.31 -0.54 -1.05 -1.17 -1.21 -13.88 -40.29 -43.19
Weighted Average Shares Out $20.51 M $18.57 M $18.39 M $17.86 M $13.17 M $8.65 M $3.51 M $414.20 K $397.66 K $355.76 K
Weighted Average Shares Out Diluted $20.51 M $18.57 M $18.39 M $17.86 M $13.17 M $8.65 M $3.51 M $428.24 K $397.66 K $355.76 K
Link